Location History:
- SE-114 41Stockholm, SE (2010)
- Stockholm, SE (2006 - 2014)
Company Filing History:
2 out of 4 
2 out of 55 
1 out of 48 
Years Active: 2006-2014
Title: Innovations of Magnus Cernerud
Introduction
Magnus Cernerud is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are therapeutically active in the central nervous system. With a total of seven patents to his name, Cernerud's work focuses on addressing serotonin-related diseases.
Latest Patents
Among his latest patents is a pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate. This invention relates to a process for preparing compounds that are therapeutically active in the central nervous system. The patent outlines the use of this compound to manufacture a medicament for treating serotonin-related disorders. Another significant patent is for (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and its salts. Similar to his previous work, this invention also focuses on the preparation of compounds that are therapeutically active in the central nervous system.
Career Highlights
Cernerud has worked with Biovitrum AB, a company known for its focus on biotechnology and pharmaceuticals. His experience in this company has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Throughout his career, Cernerud has collaborated with notable colleagues, including Helena Lundström and Margit Pelcman. These collaborations have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Magnus Cernerud's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of therapeutic compounds and their potential to treat serious health conditions.